» Articles » PMID: 22585541

Determination of Nicotine Absorption from Multiple Tobacco Products and Nicotine Gum

Overview
Specialty Public Health
Date 2012 May 16
PMID 22585541
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Snus is a smokeless tobacco product traditionally used in Scandinavia and available in pouched or loose forms. The objective of this study was to determine nicotine absorption for current pouched and loose snus products in comparison with a cigarette and an over-the-counter nicotine gum.

Methods: We conducted an open-label, randomized, 6-way, crossover study involving 20 healthy snus and cigarette users. One of 6 products (2 pouched snus, 2 weights of loose snus, a cigarette, and a nicotine gum) was administered at each of 6 visits. Blood samples were taken at intervals over 120 min and sensory perception assessed by questionnaire.

Results: For the 4 smokeless tobacco products and the nicotine gum, blood plasma levels of nicotine were ranked according to total nicotine content as follows: loose snus (27.1 mg nicotine) > pouched snus (14.7 mg nicotine) > loose snus (10.8 mg nicotine) = pouched snus (10.7 mg nicotine) > nicotine gum (4.2 mg nicotine). The area under the plasma concentration-time curve (AUC) and maximum plasma concentration (C(max)) of nicotine ranged from 26.9 to 13.1 ng.h/ml and 17.9 to 9.1 ng.h/ml, respectively across all the products. Nicotine was absorbed more rapidly from the cigarette but systemic exposure was within the range of the smokeless tobacco products (AUC = 14.8 ng.h/ml; C(max) = 12.8 ng.h/ml).

Conclusions: This study has generated new information on comparative nicotine absorption from a cigarette, loose snus, and pouched snus typical of products sold in Scandinavia. The similar nicotine absorption for 1 g portions of loose and pouched snus with approximately 11 mg of nicotine indicate that absorption kinetics were dependent on quantity of tobacco by weight and total nicotine content rather than product form.

Citing Articles

A comprehensive review: role of smokeless tobacco consumption as a risk factor for diabetes mellitus.

Rathi A, Khanam A, Khan H, Aatif M, Farhan M, Sharma R Acta Diabetol. 2025; .

PMID: 39903244 DOI: 10.1007/s00592-025-02453-y.


The association between tobacco use and COVID-19 diagnoses in three Nordic countries: a pooled analysis.

Shaaban A, Andersson F, Thiesmeier R, Orsini N, Pena S, Caspersen I Eur J Public Health. 2024; 35(1):101-107.

PMID: 39419634 PMC: 11832155. DOI: 10.1093/eurpub/ckae156.


Impact of tobacco smoking on oral cancer genetics-A next-generation sequencing perspective.

Sharma V, Kumar D, Kumar S, Singh H, Sharma N, Gupta S Imeta. 2024; 1(3):e44.

PMID: 38868711 PMC: 10989814. DOI: 10.1002/imt2.44.


Use of quantitative to extrapolation (QIVIVE) for the assessment of non-combustible next-generation product aerosols.

Moreau M, Simms L, Andersen M, Sticken E, Wieczorek R, Pour S Front Toxicol. 2024; 6:1373325.

PMID: 38665213 PMC: 11043521. DOI: 10.3389/ftox.2024.1373325.


Initial evidence of the acute effect of electronic nicotine delivery system use on energy intake.

Maldonado G, Hochsmann C, Anbil A, Neubig K, Imran R, Fuemmeler B Exp Clin Psychopharmacol. 2024; 32(4):465-474.

PMID: 38358733 PMC: 11851343. DOI: 10.1037/pha0000710.


References
1.
Robertson D, Tseng C, Appalsamy M . Smoking and mechanisms of cardiovascular control. Am Heart J. 1988; 115(1 Pt 2):258-63. DOI: 10.1016/0002-8703(88)90646-1. View

2.
Andersson G, Bjornberg G, Curvall M . Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J Oral Pathol Med. 1994; 23(4):161-7. DOI: 10.1111/j.1600-0714.1994.tb01106.x. View

3.
Haberl M, Anwald B, Klein K, Weil R, Fuss C, Gepdiremen A . Three haplotypes associated with CYP2A6 phenotypes in Caucasians. Pharmacogenet Genomics. 2005; 15(9):609-24. DOI: 10.1097/01.fpc.0000171517.22258.f1. View

4.
Lunell E, Curvall M . Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum. Nicotine Tob Res. 2011; 13(7):573-8. DOI: 10.1093/ntr/ntr044. View

5.
Russell M, Jarvis M, Feyerabend C, FERNO O . Nasal nicotine solution: a potential aid to giving up smoking?. Br Med J (Clin Res Ed). 1983; 286(6366):683-4. PMC: 1547064. DOI: 10.1136/bmj.286.6366.683. View